150 related articles for article (PubMed ID: 19940028)
1. Noninvasive functional liver blood flow measurement: comparison between bolus dose and steady-state clearance of sorbitol in a small-rodent model.
van der Hoven B; van Pelt H; Swart EL; Bonthuis F; Tilanus HW; Bakker J; Gommers D
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G177-81. PubMed ID: 19940028
[TBL] [Abstract][Full Text] [Related]
2. Rapid determination of functional liver plasma flow in ICU patients by a modified hepatic D-sorbitol plasma clearance method.
Köppel C; Pohle S; Müller C
Eur J Drug Metab Pharmacokinet; 1993; 18(4):327-31. PubMed ID: 8020530
[TBL] [Abstract][Full Text] [Related]
3. Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow.
Molino G; Cavanna A; Avagnina P; Ballaré M; Torchio M
Dig Dis Sci; 1987 Jul; 32(7):753-8. PubMed ID: 3595388
[TBL] [Abstract][Full Text] [Related]
4. Sorbitol clearance: a parameter reflecting liver plasma flow in the rat.
Molino G; Avagnina P; Cavanna A; Ballarè M; Torchio M; Bona B; Belforte G
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):119-32. PubMed ID: 3715193
[TBL] [Abstract][Full Text] [Related]
5. Sorbitol as a test substance for measurement of liver plasma flow in humans.
Keiding S; Engsted E; Ott P
Hepatology; 1998 Jul; 28(1):50-6. PubMed ID: 9657096
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume.
Li YM; Lv F; Xu X; Ji H; Gao WT; Lei TJ; Ren GB; Bai ZL; Li Q
World J Gastroenterol; 2003 Sep; 9(9):2092-5. PubMed ID: 12970913
[TBL] [Abstract][Full Text] [Related]
7. C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat.
Croner RS; Lehmann TG; Fallsehr C; Herfarth C; Klar E; Kirschfink M
Microvasc Res; 2004 Mar; 67(2):182-91. PubMed ID: 15020209
[TBL] [Abstract][Full Text] [Related]
8. Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.
Burggraaf J; Schoemaker RC; Lentjes EG; Cohen AF
Eur J Pharm Sci; 2000 Dec; 12(2):133-9. PubMed ID: 11102741
[TBL] [Abstract][Full Text] [Related]
9. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
Zeeh J; Lange H; Bosch J; Pohl S; Loesgen H; Eggers R; Navasa M; Chesta J; Bircher J
Gastroenterology; 1988 Sep; 95(3):749-59. PubMed ID: 3396820
[TBL] [Abstract][Full Text] [Related]
10. The changes of hepatic sinusoidal microcirculation and effects of nitric oxide synthase inhibitor during sepsis.
Hwang TL; Han ML
Hepatogastroenterology; 2003; 50(49):213-6. PubMed ID: 12630025
[TBL] [Abstract][Full Text] [Related]
11. Caval Subtraction 2D Phase-Contrast MRI to Measure Total Liver and Hepatic Arterial Blood Flow: Proof-of-Principle, Correlation With Portal Hypertension Severity and Validation in Patients With Chronic Liver Disease.
Chouhan MD; Mookerjee RP; Bainbridge A; Punwani S; Jones H; Davies N; Walker-Samuel S; Patch D; Jalan R; Halligan S; Lythgoe MF; Taylor SA
Invest Radiol; 2017 Mar; 52(3):170-176. PubMed ID: 27805917
[TBL] [Abstract][Full Text] [Related]
12. [Evaluating liver functional reserve by combining D-sorbitol with indocyanine green measurement].
Gao WT; Li YM; Ji H; Yang WB
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):350-3. PubMed ID: 12837214
[TBL] [Abstract][Full Text] [Related]
13. Impairment of exogenous lactate clearance in experimental hyperdynamic septic shock is not related to total liver hypoperfusion.
Tapia P; Soto D; Bruhn A; Alegría L; Jarufe N; Luengo C; Kattan E; Regueira T; Meissner A; Menchaca R; Vives MI; Echeverría N; Ospina-Tascón G; Bakker J; Hernández G
Crit Care; 2015 Apr; 19(1):188. PubMed ID: 25898244
[TBL] [Abstract][Full Text] [Related]
14. The influence of reduced liver blood flow on the pharmacokinetics and pharmacodynamics of recombinant tissue factor pathway inhibitor.
Kemme MJ; Burggraaf J; Schoemaker RC; Paulson S; Karim A; Lentjes EG; Childs A; Braeckman RA; Cohen AF
Clin Pharmacol Ther; 2000 May; 67(5):504-11. PubMed ID: 10824629
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.
Tadros T; Traber DL; Herndon DN
Ann Surg; 2004 Jan; 239(1):67-74. PubMed ID: 14685102
[TBL] [Abstract][Full Text] [Related]
16. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Ott P; Keiding S; Bass L
Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
[TBL] [Abstract][Full Text] [Related]
17. Functional hepatic flow in patients with liver cirrhosis.
Pan Z; Wu XJ; Li JS; Liu FN; Li WS; Han JM
World J Gastroenterol; 2004 Mar; 10(6):915-8. PubMed ID: 15040046
[TBL] [Abstract][Full Text] [Related]
18. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis.
Jiao LR; Seifalian AM; Habib N; Davidson BR
Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637
[TBL] [Abstract][Full Text] [Related]
19. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis.
Zoli M; Magalotti D; Bianchi G; Ghigi G; Orlandini C; Grimaldi M; Marchesini G; Pisi E
J Hepatol; 1995 Aug; 23(2):129-34. PubMed ID: 7499783
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.
Chouhan MD; Taylor SA; Bainbridge A; Walker-Samuel S; Davies N; Halligan S; Lythgoe MF; Mookerjee RP
Eur Radiol; 2021 Apr; 31(4):2518-2528. PubMed ID: 33044649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
